News
-
CD40 expression correlates with response to immunotherapy in melanoma patients
L-R: Ann Richmond, Chi Yan By Wendy Bindeman Ann Richmond, professor of pharmacology, and Chi Yan, a research assistant professor in the Richmond lab, recently published a study showing that expression of a protein called CD40 can be used to predict response to immunotherapy in malignant melanoma. Read MoreMar. 1, 2022
-
Discovery of a pathway that regulates heart muscle regeneration
Research led by Dylan Burnette, associate professor of cell and developmental biology, and first-author Abigail Neininger, a graduate student in the Burnette lab, identified the Hippo pathway as a key regulator of heart muscle cell division, which has large translational implications for treatments after a heart attack. Their article was… Read MoreSep. 9, 2021
-
Scott Hiebert to serve as acting chair for the National Cancer Advisory Board
By Lorena Infante Lara Scott Hiebert, Hortense B. Ingram Chair in Cancer Research and professor of biochemistry, will serve as acting chair for the National Cancer Advisory Board. Originally appointed by President Barack Obama… Read MoreSep. 28, 2020